Buyer profile
UK Health Security Agency
Get alerts when UK Health Security Agency publishes a new tender — 7-day free trial, then £4.99/month.
Total contracts
88
Known spend
£7bn
75 disclosed
Average value
£95m
Per contract
Active suppliers
10
Last 5 years
Top suppliers
Last 5 years- 1
Softcat plc
4 winslatest 23 Sept 2026£1m
- 2
Helix Biotech, Inc.
3 winslatest 18 Dec 2025£450,000
- 3
QCMD (Quality Control for Molecular Diagnostics)
2 winslatest 15 Jul 2025£901,000
- 4
Scientific Laboratory Supplies Limited
2 winslatest 29 Jul 2026£655,968
- 5
CIPD Enterprises Limited
2 winslatest 18 Jul 2025£115,920
- 6
Allianz Engineering Inspection Services Limited
2 winslatest 06 Jun 2025£88,018
- 7
Camlab Limited
2 winslatest 30 Sept 2026£67,168
- 8
ROCHE PRODUCTS LIMITED
£2
- 9
RANDOX CLINICAL LABORATORY SERVICES LTD
1 winlatest 12 Jun 2026£331m
- 10
Foundever GB Ltd
1 winlatest 24 Jun 2026£144m
What they buy
By CPV categorySoftwareCPV 48
9 contracts · £13m
Medical equipment & pharmaCPV 33
8 contracts · £1bn
Lab & precision equipmentCPV 38
6 contracts · £87,349
IT servicesCPV 72
3 contracts · £5m
Industrial machineryCPV 42
3 contracts · £11,968
Travel & freightCPV 63
1 contract · £5m
Architectural & engineeringCPV 71
1 contract · £189,764
Repair & maintenanceCPV 50
1 contract · £106,526
Renewal radar
Awarded contracts predicted to come up for re-tender in the next 18 months
- Altona Kits & Consumables
Predicted using median duration of past contracts from this buyer in the same CPV division (12 months from contract start date → renewal expected by Aug 2027).
Aug 2027
60% confident
- OHID Development 26/27
Predicted using median duration of UK contracts in the same CPV division (20 months from contract start date → renewal expected by Jan 2028).
Jan 2028
40% confident
- SARS-CoV-2 Adult Vaccine Supply (2026)
Predicted using median duration of UK contracts in the same CPV division (20 months from contract start date → renewal expected by Feb 2028).
Feb 2028
40% confident
- Consumable Contract for SLS
Predicted using median duration of UK contracts in the same CPV division (20 months from contract start date → renewal expected by Feb 2028).
Feb 2028
40% confident
- Abbott Maintenance, UKHSA Birmingham Laboratory
Predicted using median duration of UK contracts in the same CPV division (23 months from contract start date → renewal expected by Mar 2028).
Mar 2028
40% confident
- Serosep Consumables
Predicted using median duration of UK contracts in the same CPV division (20 months from contract start date → renewal expected by Mar 2028).
Mar 2028
40% confident
- Plate reader (Glomax) 26/27
Predicted using median duration of UK contracts in the same CPV division (20 months from contract start date → renewal expected by Mar 2028).
Mar 2028
40% confident
Tender activity
Notices published per month — last 24 months
All contracts (88)
Anguilla street doctors LTD education/training
Anguilla Young People’s Mental Health Training Programme
NEC contract licences 25/26
This contract is for the provision of NEC contract licences, UKHSA use various versions of standard form NEC contracts for construction, facilities management and professional serv
Engineering inspection services 2025
This contract will provide a suitably appropriate engineering inspection regime for all UKHSA sites.
Engineering inspection services 2025
This contract will provide a suitably appropriate engineering inspection regime for all UKHSA sites.
West technology service and maintenance contract
Service and Maintenance Contract : Annual Servicing of Twin Catch Pot machines at London, Porton and York FW&E.
Ukhsa provision for NLA media access licence agreement
The NLA licence is necessary for UKHSA media monitoring service.
Cyber security - industrial automated control systems (IACS).
This contract is for the supply of expert consultancy and delivery support to risk assess and remediate cyber risks on the IACS estate.
Ukhsa wide - general works
UKHSA are exploring a solution for delivering General Works within its key estates including but not limited to: UKHSA Porton, UKHSA Colindale, and UKHSA Chilton. General works wil
Porton - main plenum replacement
The removal and replacement of full ventilation system within the Main Plenum Building with full associated asbestos controls
Meningococcal ACWY vaccine (2027)
Meningococcal ACWY vaccine supply (2027). Estimated Total Value withheld due to commercial sensitivity (s.94(1)(b)). Publication of this information would be likely to prejudice of
Meningitis B vaccine (2026)
Meningitis B vaccine supply (2026). Estimated Total Value withheld due to commercial sensitivity (s.94(1)(b)). Publication of this information would be likely to prejudice of comme
Pneumococcal conjugate vaccine for children (2026)
Pneumococcal conjugate vaccine for children (2026). Estimated Total Value withheld due to commercial sensitivity (s.94(1)(b)). Publication of this information would be likely to pr
RSV immunisation products - infants (2028)
RSV immunisation products - Infants (2028). Estimated Total Value withheld due to commercial sensitivity (s.94(1)(b)). Publication of this information would be likely to prejudice
RSV immunisation products - adults (2028)
RSV immunisation products - Adults (2028). Estimated Total Value withheld due to commercial sensitivity (s.94(1)(b)). Publication of this information would be likely to prejudice o
Centralised adult flu procurement under dynamic market
Call for competition by reference to Vaccines Dynamic Market. Estimated Total Value withheld due to commercial sensitivity (s.94(1)(b)). Publication of this information would be li
Centralised adult flu dynamic market
Long term supply of centrally procured Adult Flu vaccines via Dynamic Market. Estimated Total Value withheld due to commercial sensitivity (s.94(1)(b)). Publication of this informa
Ukhsa diagnostics and research open framework
A Framework to procure laboratory diagnostic consumables, equipment and services as well as Research Consumables, Equipment and Services
Atnna
A combined autoinjector of pralidoxime chloride and atropine. Estimated Total Value withheld due to commercial sensitivity (s.94(1)(b)). Publication of this information would be li
BCG (tuberculosis) vaccine (2027)
BCG (tuberculosis) vaccine supply (2027). Estimated Total Value withheld due to commercial sensitivity (s.94(1)(b)). Publication of this information would be likely to prejudice of
Herpes zoster vaccine, inactivated (2027)
Herpes zoster vaccine, inactivated (2027). Estimated Total Value withheld due to commercial sensitivity (s.94(1)(b)). Publication of this information would be likely to prejudice o